Skip to main content
. 2012 May 31;4:22. doi: 10.1186/1758-5996-4-22

Table 1.

Characteristics overall and for men and women

Variables Men (157) Women (151) P-value Total (308)
Mean age, years (SD)
55.6 (10.1)
56 (10.9)
0.74
55.8 (10.5)
Known duration of diabetes*
3.0 (0.5-5.0)
3.0 (0.5-5.0)
0.46
3.0 (0.5-5.0)
Mean BMI, kg/m2 (SD)
27.0 (4.2)
28.8 (5.0)
<0.001
27.9 (4.7)
Mean waist circumference, cm (SD)
95.9 (9.6)
97.4 (11.0)
0.20
96.6 (10.4)
Mean systolic blood pressure, mm Hg (SD)
142.9 (24.5)
142.8 (25.2)
0.95
142.7 (24.8)
Mean diastolic blood pressure, mm Hg (SD)
84.3 (11.9)
83.0 (11.8)
0.37
83.7 (11.9)
Hypertension, n (%)
84 (53.5%)
83 (55%)
0.80
167 (54.2%)
Smoking, n (%)
13 (8.3%)
2 (1.3%)
0.003
15 (4.9%)
Mean total cholesterol, g/L (SD)
1.78 (0.56)
1.80 (0.52)
0.79
1.79 (0.54)
Mean LDL cholesterol, g/L (SD)
1.10 (0.53)
1.12 (0.49)
0.69
1.11 (0.51)
Mean HDL cholesterol, g/L (SD)
0.53 (0.21)
0.58 (0.22)
0.04
0.56 (0.22)
Triglycerides (g/l)*
0.92 (0.65-1.25)
0.84 (0.58-1.26)
0.41
0.88 (0.63-1.26)
Mean fasting glucose, g/L (SD)
1.57 (0.64)
1.48 (0.61)
0.25
1.53 (0.62)
Mean post-prandial glucose, g/l (SD)
1.96 (0.86)
1.78 (0.81)
0.04
1.87 (0.84)
Glucose control treatments
 
 
 
 
Oral agents, n (%)
114 (72.6%)
108 (71.5%)
0.83
222 (72.1%)
Insulin, n (%)
32 (20.4%)
46 (30.5%)
0.04
78 (25.3%)
Insulin and Oral agents, n (%)
8 (5.1%)
18 (11.9%)
0.04
26 (8.4%)
Blood pressure lowering medications, n (%)
65 (41.4%)
73 (48.3%)
0.22
138 (44.8%)
Statins use, n (%)
2 (1.3%)
1 (0.7%)
0.58
3 (1%)
Aspirin use, n (%) 2 (1.3%) 2 (1.3%) > 0.99 4 (1.3%)

* Values are Median (25th – 75th percentiles).